WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2008095999) PYRIMIDINE SUBSTITUTED MACROCYCLIC HCV INHIBITORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2008/095999    International Application No.:    PCT/EP2008/051553
Publication Date: 14.08.2008 International Filing Date: 08.02.2008
IPC:
C07D 403/12 (2006.01), C07K 5/06 (2006.01)
Applicants: TIBOTEC PHARMACEUTICALS LTD. [IE/IE]; Eastgate Village, Eastgate, Little Island, Co Cork (IE) (For All Designated States Except US).
MEDIVIR AB [SE/SE]; Lunastigen 7, S-14144 Huddinge (SE) (For All Designated States Except US).
RABOISSON, Pierre Jean-Marie Bernard [FR/BE]; (BE) (For US Only).
BELFRAGE, Anna, Karin, Gertrud, Linnea [SE/SE]; (SE) (For US Only).
CLASSON, Björn, Olof [SE/SE]; (SE) (For US Only).
LINDQUIST, Karin, Charlotta [SE/SE]; (SE) (For US Only).
NILSSON, Karl, Magnus [SE/SE]; (SE) (For US Only).
ROSENQUIST, Åsa, Annica, Kristina [SE/SE]; (SE) (For US Only).
SAMUELSSON, Bengt, Bertil [SE/SE]; (SE) (For US Only).
WÄHLING, Horst, Jürgen [DE/SE]; (SE) (For US Only)
Inventors: RABOISSON, Pierre Jean-Marie Bernard; (BE).
BELFRAGE, Anna, Karin, Gertrud, Linnea; (SE).
CLASSON, Björn, Olof; (SE).
LINDQUIST, Karin, Charlotta; (SE).
NILSSON, Karl, Magnus; (SE).
ROSENQUIST, Åsa, Annica, Kristina; (SE).
SAMUELSSON, Bengt, Bertil; (SE).
WÄHLING, Horst, Jürgen; (SE)
Agent: WANTE, Dirk; Tibotec-Virco Comm. VA, J & J Patent Law Department, Generaal De Wittelaan L 11B 3, B-2800 Mechelen (BE)
Priority Data:
07102005.1 08.02.2007 EP
Title (EN) PYRIMIDINE SUBSTITUTED MACROCYCLIC HCV INHIBITORS
(FR) INHIBITEURS MACROCYCLIQUES DU VIRUS DE L'HÉPATITE C (VHC) SUBSTITUÉS PAR PYRIMIDINE
Abstract: front page image
(EN)Compounds of the Formula (I) including a stereoisomer thereof, or an N-oxide, a pharmaceutically acceptable addition salt, or a pharmaceutically acceptable addition solvate thereof; useful as HCV inhibitors; processes for preparing these compounds as well as pharmaceutical compositions comprising these compounds as active ingredient.
(FR)L'invention concerne des composés de formule (I) comprenant un stéréoisomère ou un N-oxyde, ou un sel d'addition pharmaceutiquement acceptable ou un solvate d'addition pharmaceutiquement acceptable. Ces composés sont utiles comme inhibiteurs du virus de l'hépatite C (VHC). L'invention concerne également des procédés de préparation de ces composés, ainsi que des compositions pharmaceutiques les comprenant et agissant comme ingrédient actif.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)